Ironwood Pharmaceuticals (IRWD) Price to FCF (2010 - 2026)

Ironwood Pharmaceuticals has disclosed Price to FCF across 17 years of filings, most recently posting 11.94 for Q2 2026.

• In Q2 2026, Price to FCF rose 253.82% year-over-year to 11.94; the TTM figure through Jun 2026 stood at 3.75 (down 4.04% YoY), while the FY2025 annual figure was 4.33, down 36.96% from the prior year.
• Price to FCF came in at 11.94 for Q2 2026 at Ironwood Pharmaceuticals, down from 112.83 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 112.83 in Q1 2026 to a low of 7.76 in Q2 2025.
• Average Price to FCF over 5 years is 32.62, with a median of 29.63 recorded in 2022.
• Year-over-year, Price to FCF tumbled 124.89% in 2025 and surged 845.04% in 2026.
• Over 5 years, Price to FCF stood at 24.09 in 2022, then soared by 108.41% to 50.21 in 2023, then decreased by 7.1% to 46.65 in 2024, then sank by 84.2% to 7.37 in 2025, then soared by 62.01% to 11.94 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 11.94 in Q2 2026, 112.83 in Q1 2026, and 7.37 in Q4 2025.